Terumo Corp (4543) - Product Pipeline Analysis, 2023 Update

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $750	103 Pages	GlobalData	July, 2023	GBDT18100617

Best Price Guarantee
Price	from $750
Length	103 Pages
Publisher	GlobalData
Published Date	July, 2023
SKU	GBDT18100617

North America Flat Glass Market Summary, Competitive Analysis and Forecast to 2027

Summary

Flat Glass in North America industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

Flat glass is typically used for windows and other applications, including glass tables and doors. It is also known as plate glass and sheet glass. By end-use, the market is segmented into building & construction, automotive, and others. The scope of others segment includes electronics, solar PV, and furniture.
The North American flat glass market had total revenues of $18.1 billion in 2022, representing a compound annual growth rate (CAGR) of 2.3% between 2017 and 2022.
Market consumption volume increased with a CAGR of 2.3% between 2017 and 2022, to reach a total of 12 million Tons in 2022.
The volume of the flat glass in the market witnessed an increase of 4.6% in 2022 as compared to 4.4% in 2021. Increasing growth in the automotive industry is the underlying factor driving the global flat glass market growth.

Scope

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the flat glass market in North America
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the flat glass market in North America
Leading company profiles reveal details of key flat glass market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the North America flat glass market with five year forecasts

Reasons to Buy

What was the size of the North America flat glass market by value in 2022?
What will be the size of the North America flat glass market in 2027?
What factors are affecting the strength of competition in the North America flat glass market?
How has the market performed over the last five years?
What are the main segments that make up North America's flat glass market?

Terumo Corp Company Overview: Terumo Corp Company Snapshot; Terumo Corp Pipeline Products and Ongoing Clinical Trials Overview; Terumo Corp – Pipeline Analysis Overview; Business Description; Terumo Corp - Key Facts; Terumo Corp - Major Products and Services; Terumo Corp Pipeline Products by Development Stage; Terumo Corp Ongoing Clinical Trials by Trial Status; Terumo Corp Pipeline Products Overview; Advanced Coil; Advanced Coil Product Overview; Advanced WEB Aneurysm Embolization Device; Advanced WEB Aneurysm Embolization Device Product Overview; AI-Based Percutaneous Coronary Intervention System; AI-Based Percutaneous Coronary Intervention System Product Overview; AortaFit System; AortaFit System Product Overview; AortaFit System Clinical Trial; Atherectomy Device; Atherectomy Device Product Overview; Balloon Guide Catheter; Balloon Guide Catheter Product Overview; BoulEVARd Stent; BoulEVARd Stent Product Overview; CMOS Image Glucose Sensor; CMOS Image Glucose Sensor Product Overview; Coated Stent; Coated Stent Product Overview; Coil Assist Stent; Coil Assist Stent Product Overview; Cross-Seal System; Cross-Seal System Product Overview; Digital Healthcare Support System; Digital Healthcare Support System Product Overview; Digital Therapy Support System; Digital Therapy Support System Product Overview; Fineglide; Fineglide Product Overview; Flash PTCA; Flash PTCA Product Overview; FRED X; FRED X Product Overview; Hybrid Stent Graft; Hybrid Stent Graft Product Overview; Infusion Pump; Infusion Pump Product Overview; Izanai; Izanai Product Overview; Kaitoh Atherectomy System; Kaitoh Atherectomy System Product Overview; Kaitoh Atherectomy System Clinical Trial; Kenma; Kenma Product Overview; Large Volume Injector; Large Volume Injector Product Overview; Liver Cancer Ablation System; Liver Cancer Ablation System Product Overview; Mirasol Pathogen Reduction Technology System - Platelets & Plasma; Mirasol Pathogen Reduction Technology System - Platelets & Plasma Product Overview; Mirasol Pathogen Reduction Technology System - Whole Blood; Mirasol Pathogen Reduction Technology System - Whole Blood Product Overview; MISAGO RX Self-Expanding Stent System; MISAGO RX Self-Expanding Stent System Product Overview; MISAGO RX Self-Expanding Stent System Clinical Trial; Nesaku; Nesaku Product Overview; Next Generation Ultimaster Drug Eluting Bioresorbable Scaffold; Next Generation Ultimaster Drug Eluting Bioresorbable Scaffold Product Overview; Next Ultimaster Metallic Drug Eluting Stent; Next Ultimaster Metallic Drug Eluting Stent Product Overview; Ophthalmic Needle; Ophthalmic Needle Product Overview; Optimal Dosing System; Optimal Dosing System Product Overview; Opuswave; Opuswave Product Overview; Plasmapheresis Device; Plasmapheresis Device Product Overview; Plastic Needle; Plastic Needle Product Overview; QuiremSpheres; QuiremSpheres Product Overview; QuiremSpheres Clinical Trial; QuiremSpheres - Brain Tumor; QuiremSpheres - Brain Tumor Product Overview; QuiremSpheres - Pancreatic Tumor; QuiremSpheres - Pancreatic Tumor Product Overview; QuiremSpheres - Pancreatic Tumor Clinical Trial; Radial Access Closure Device; Radial Access Closure Device Product Overview; RelayBranch Thoracic Stent-Graft System; RelayBranch Thoracic Stent-Graft System Product Overview; RelayBranch Thoracic Stent-Graft System Clinical Trial; RelayPro Thoracic Stent-Graft System - Acute Complicated Type B Thoracic Aortic Dissection; RelayPro Thoracic Stent-Graft System - Acute Complicated Type B Thoracic Aortic Dissection Product Overview; RelayPro Thoracic Stent-Graft System - Acute Complicated Type B Thoracic Aortic Dissection Clinical Trial; RelayPro Thoracic Stent-Graft System - Blunt Traumatic Aortic Injury; RelayPro Thoracic Stent-Graft System - Blunt Traumatic Aortic Injury Product Overview; Renal Sympathetic Denervation System - TRI Technique; Renal Sympathetic Denervation System - TRI Technique Product Overview; Robotic Surgical Support Device; Robotic Surgical Support Device Product Overview; Runner PTCA Balloon Catheter; Runner PTCA Balloon Catheter Product Overview; Runner Slim PTCA; Runner Slim PTCA Product Overview; Smartphone-Type Device - MEDISAFE WITH; Smartphone-Type Device - MEDISAFE WITH Product Overview; Structural Heart Disease Device; Structural Heart Disease Device Product Overview; TERUMO Surshield-PUR Safety I.V. Catheter; TERUMO Surshield-PUR Safety I.V. Catheter Product Overview; TF Press; TF Press Product Overview; Thoracoabdominal Hybrid Device; Thoracoabdominal Hybrid Device Product Overview; TREOVANCE Abdominal Stent Graft With Navitel Delivery System; TREOVANCE Abdominal Stent Graft With Navitel Delivery System Product Overview; TREOVANCE Abdominal Stent Graft With Navitel Delivery System Clinical Trial; Ultimaster Nagomi; Ultimaster Nagomi Product Overview; Ultimaster Nagomi Clinical Trial; Wrist Artery Guidewire; Wrist Artery Guidewire Product Overview; Terumo Corp - Key Competitors; Terumo Corp - Key Employees; Terumo Corp - Key Employee Biographies; Terumo Corp - Locations And Subsidiaries; Head Office; Other Locations & Subsidiaries; Recent Developments; Terumo Corp, Recent Developments; May 15, 2023: Terumo announces consolidated financial results for the fiscal year ended March 31, 2023; Mar 13, 2023: Terumo prospective registry reinforces safety, efficacy and efficiency of radial access in visceral interventions (R.A.V.I.) in embolization procedures; Feb 09, 2023: Terumo Corp Announces Consolidated Financial Results for the Third Quarter Ended December 31, 2022; Feb 09, 2023: Terumo Notice Concerning Revision of the Full-Year Financial Guidance for Fiscal Year Ending March 31, 2023; Jan 25, 2023: Terumo and Siemens Healthineers India collaborate to strengthen cardiac care in India; Dec 28, 2022: Inspira Technologies signs strategic OEM agreement with Terumo Cardiovascular; Nov 10, 2022: Terumo Corp Announces Consolidated Financial Results for the Second Quarter Ended September 30, 2022; Nov 01, 2022: New randomized controlled study published in JAMA demonstrates the value of clinical decision support tools in preventing acute kidney injury in patients undergoing coronary angiography; Nov 04, 2021: Terumo Corp Half Yearly Results For the Period 30 September 2021; Oct 21, 2021: Terumo Blood and Cell Technologies opens manufacturing facility in Costa Rica; Appendix; Methodology; About GlobalData; Contact Us; Disclaimer
List of Tables: Table 1: Terumo Corp Pipeline Products and Ongoing Clinical Trials Overview; Table 2: Terumo Corp Pipeline Products by Equipment Type; Table 3: Terumo Corp Pipeline Products by Indication; Table 4: Terumo Corp, Key Facts; Table 5: Terumo Corp, Major Products and Services; Table 6: Terumo Corp Number of Pipeline Products by Development Stage; Table 7: Terumo Corp Pipeline Products Summary by Development Stage; Table 8: Terumo Corp Ongoing Clinical Trials by Trial Status; Table 9: Terumo Corp Ongoing Clinical Trials Summary; Table 10: Advanced Coil - Product Status; Table 11: Advanced Coil - Product Description; Table 12: Advanced WEB Aneurysm Embolization Device - Product Status; Table 13: Advanced WEB Aneurysm Embolization Device - Product Description; Table 14: AI-Based Percutaneous Coronary Intervention System - Product Status; Table 15: AI-Based Percutaneous Coronary Intervention System - Product Description; Table 16: AortaFit System - Product Status; Table 17: AortaFit System - Product Description; Table 18: AortaFit System - Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Juxtarenal Aortic Aneurysm: An Investigator Initiated Study; Table 19: Atherectomy Device - Product Status; Table 20: Atherectomy Device - Product Description; Table 21: Balloon Guide Catheter - Product Status; Table 22: Balloon Guide Catheter - Product Description; Table 23: BoulEVARd Stent - Product Status; Table 24: BoulEVARd Stent - Product Description; Table 25: CMOS Image Glucose Sensor - Product Status; Table 26: CMOS Image Glucose Sensor - Product Description; Table 27: Coated Stent - Product Status; Table 28: Coated Stent - Product Description; Table 29: Coil Assist Stent - Product Status; Table 30: Coil Assist Stent - Product Description; Table 31: Cross-Seal System - Product Status; Table 32: Cross-Seal System - Product Description; Table 33: Digital Healthcare Support System - Product Status; Table 34: Digital Healthcare Support System - Product Description; Table 35: Digital Therapy Support System - Product Status; Table 36: Digital Therapy Support System - Product Description; Table 37: Fineglide - Product Status; Table 38: Fineglide - Product Description; Table 39: Flash PTCA - Product Status; Table 40: Flash PTCA - Product Description; Table 41: FRED X - Product Status; Table 42: FRED X - Product Description; Table 43: Hybrid Stent Graft - Product Status; Table 44: Hybrid Stent Graft - Product Description; Table 45: Infusion Pump - Product Status; Table 46: Infusion Pump - Product Description; Table 47: Izanai - Product Status; Table 48: Izanai - Product Description; Table 49: Kaitoh Atherectomy System - Product Status; Table 50: Kaitoh Atherectomy System - Product Description; Table 51: Kaitoh Atherectomy System - Kaitoh Atherectomy System: Peripheral Artery Revascularization of Stenotic/Restenotic Disease Using the Atherectomy System in the Peripheral Arteries; Table 52: Kenma - Product Status; Table 53: Kenma - Product Description; Table 54: Large Volume Injector - Product Status; Table 55: Large Volume Injector - Product Description; Table 56: Liver Cancer Ablation System - Product Status; Table 57: Liver Cancer Ablation System - Product Description; Table 58: Mirasol Pathogen Reduction Technology System - Platelets & Plasma - Product Status; Table 59: Mirasol Pathogen Reduction Technology System - Platelets & Plasma - Product Description; Table 60: Mirasol Pathogen Reduction Technology System - Whole Blood - Product Status; Table 61: Mirasol Pathogen Reduction Technology System - Whole Blood - Product Description; Table 62: MISAGO RX Self-Expanding Stent System - Product Status; Table 63: MISAGO RX Self-Expanding Stent System - Product Description; Table 64: MISAGO RX Self-Expanding Stent System - Occlusive/Stenotic Peripheral Artery Revascularization Study for Common And/Or External ILIAC Artery using the Misago Rx Self-expanding Peripheral Stent:OSPREY ILIAC; Table 65: Nesaku - Product Status; Table 66: Nesaku - Product Description; Table 67: Next Generation Ultimaster Drug Eluting Bioresorbable Scaffold - Product Status; Table 68: Next Generation Ultimaster Drug Eluting Bioresorbable Scaffold - Product Description; Table 69: Next Ultimaster Metallic Drug Eluting Stent - Product Status; Table 70: Next Ultimaster Metallic Drug Eluting Stent - Product Description; Table 71: Ophthalmic Needle - Product Status; Table 72: Ophthalmic Needle - Product Description; Table 73: Optimal Dosing System - Product Status; Table 74: Optimal Dosing System - Product Description; Table 75: Opuswave - Product Status; Table 76: Opuswave - Product Description; Table 77: Plasmapheresis Device - Product Status; Table 78: Plasmapheresis Device - Product Description; Table 79: Plastic Needle - Product Status; Table 80: Plastic Needle - Product Description; Table 81: QuiremSpheres - Product Status; Table 82: QuiremSpheres - Product Description; Table 83: QuiremSpheres - Clinical Investigation Evaluating Safety and Efficacy of Selective Intra-arterial 166Holmium Radiation Therapy in Combination With Atezolizumab and Bevacizumab for Non Resectable Hepatocellular Carcinoma; Table 84: QuiremSpheres - Clinical Validation of a Fractional Administration Device for Holmium-166 Microspheres During Selective Internal Radiation Therapy in Patients With Liver Tumours; Table 85: QuiremSpheres - Holmium-166 Transarterial Radioembolization in Unresectable, Early Stage Hepatocellular Carcinoma; a Prospective, Single-arm, Open Label, Multicenter Phase II Study: HOMIE-166; Table 86: QuiremSpheres - Brain Tumor - Product Status; Table 87: QuiremSpheres - Brain Tumor - Product Description; Table 88: QuiremSpheres - Pancreatic Tumor - Product Status; Table 89: QuiremSpheres - Pancreatic Tumor - Product Description; Table 90: QuiremSpheres - Pancreatic Tumor - Intratumoral Holmium Microspheres Brachytherapy for Patients With Pancreatic Cancer; a Single Center, Non-randomized, Feasibility Study in an Open Surgical Setting - The SLOTH1 Study; Table 91: QuiremSpheres - Pancreatic Tumor - Percutaneous Intratumoural Holmium Microspheres Brachytherapy for Patients with Pancreatic Cancer; A Single Centre, Prospective Safety and Feasibility Study; Table 92: Radial Access Closure Device - Product Status; Table 93: Radial Access Closure Device - Product Description; Table 94: RelayBranch Thoracic Stent-Graft System - Product Status; Table 95: RelayBranch Thoracic Stent-Graft System - Product Description; Table 96: RelayBranch Thoracic Stent-Graft System - A Prospective, Multicenter, Non-blinded, Non-randomized Early Feasibility Study of the Relay Branch Thoracic Stent-graft System in Subjects with Thoracic Aortic Pathologies Requiring Treatment Proximal to the Origin of the Innominate Artery; Table 97: RelayBranch Thoracic Stent-Graft System - Cerebral Hemodynamics and Microemboli During Placement of RelayBranch Thoracic Stent-Graft System; Table 98: RelayBranch Thoracic Stent-Graft System - ENDOBARC-S Study: Endovascular Branched Stent-grafts for Aortic ARCh Pathologies in Spain; Table 99: RelayPro Thoracic Stent-Graft System - Acute Complicated Type B Thoracic Aortic Dissection - Product Status; Table 100: RelayPro Thoracic Stent-Graft System - Acute Complicated Type B Thoracic Aortic Dissection - Product Description; Table 101: RelayPro Thoracic Stent-Graft System - Acute Complicated Type B Thoracic Aortic Dissection - A Prospective, Multi-center, Non-blinded, Non-randomized Study of the RelayPro Thoracic Stent-graft in Subjects with an Acute, Complicated Type B Aortic Dissection; Table 102: RelayPro Thoracic Stent-Graft System - Acute Complicated Type B Thoracic Aortic Dissection - Thoraflex Hybrid and Relay Extension Post-Approval Study; Table 103: RelayPro Thoracic Stent-Graft System - Blunt Traumatic Aortic Injury - Product Status; Table 104: RelayPro Thoracic Stent-Graft System - Blunt Traumatic Aortic Injury - Product Description; Table 105: Renal Sympathetic Denervation System - TRI Technique - Product Status; Table 106: Renal Sympathetic Denervation System - TRI Technique - Product Description; Table 107: Robotic Surgical Support Device - Product Status; Table 108: Robotic Surgical Support Device - Product Description; Table 109: Runner PTCA Balloon Catheter - Product Status; Table 110: Runner PTCA Balloon Catheter - Product Description; Table 111: Runner Slim PTCA - Product Status; Table 112: Runner Slim PTCA - Product Description; Table 113: Smartphone-Type Device - MEDISAFE WITH - Product Status; Table 114: Smartphone-Type Device - MEDISAFE WITH - Product Description; Table 115: Structural Heart Disease Device - Product Status; Table 116: Structural Heart Disease Device - Product Description; Table 117: TERUMO Surshield-PUR Safety I.V. Catheter - Product Status 7; Table 118: TERUMO Surshield-PUR Safety I.V. Catheter - Product Description 7; Table 119: TF Press - Product Status; Table 120: TF Press - Product Description; Table 121: Thoracoabdominal Hybrid Device - Product Status; Table 122: Thoracoabdominal Hybrid Device - Product Description; Table 123: TREOVANCE Abdominal Stent Graft With Navitel Delivery System - Product Status; Table 124: TREOVANCE Abdominal Stent Graft With Navitel Delivery System - Product Description; Table 125: TREOVANCE Abdominal Stent Graft With Navitel Delivery System - Anatomical Feasibility of an Off-the-shelf Scalloped Stent-graft for Infrarenal Abdominal Aneurysm with a Hostile Neck (ReSTHoNe Study); Table 126: Ultimaster Nagomi - Product Status; Table 127: Ultimaster Nagomi - Product Description; Table 128: Ultimaster Nagomi - A Post-Market Clinical Follow-up Study With Ultimaster Nagomi Sirolimus Eluting Coronary Stent System in Complex PCI Subjects; Table 129: Wrist Artery Guidewire - Product Status; Table 130: Wrist Artery Guidewire - Product Description; Table 131: Terumo Corp, Key Employees; Table 132: Terumo Corp, Key Employee Biographies; Table 133: Terumo Corp, Other Locations; Table 134: Terumo Corp, Subsidiaries; Table 135: Glossary
List of Figures: Figure 1: Terumo Corp Pipeline Products by Equipment Type; Figure 2: Terumo Corp Pipeline Products by Development Stage; Figure 3: Terumo Corp Ongoing Clinical Trials by Trial Status